ABZU

Accelerating life science + drug development

WHAT WE DO >
HOW WE DO IT >
Abzu logo sparkle

OUR CLIENTS >

TESTIMONIALS >

PUBLICATIONS >

Clients we are proud to disclose

ACCELERATING DRUG DEVELOPMENT

Abzu closes the drug and target discovery loop

Understand the basis of disease, and identify novel points of intervention.

Determine the underlying mechanisms to optimize high-throughput screening.

Reveal drug-target interaction signatures from in vivo, in vitro, and in silico data.

Improve hit-rate by explaining selectivity, toxicity, and activity drivers.

And after approval…

MARKET ACCESS >

CLINICAL DECISION SUPPORT >

dr.evidence
Hypotheses generated by Abzu's explainable AI, the QLattice, are brilliantly put into context with our knowledge graphs. I believe a combined setup like ours is a very realistic picture of the future of data science.

Umut Eser,

CIO

Roche
While we consider ourselves world-leading in the computational design of oligonucleotide-based therapies, our collaboration with Abzu has added new aspects when applying machine learning to drug discovery data.

Morten Lindow,

Therapeutic Modalities

Statens Serum Institut - SSI
Collaborating with Abzu has led to highly significant new knowledge. Using the QLattice in combination with biomarkers, as well as medical and social register data, is a very promising approach to perosnalized medicine.

Michael Christiansen

Chief Physician

COV-IRT Covid International Research Team
Collaborating with Abzu helped identify quantifiable key drivers that led to discovering the key biomarkers involved with SARS-CoV-2 infection. Abzu was able to enrich our understanding and produce novel analyses.

Afshin Beheshti,

President

Abzu's Beer, Data, + Drugs event

SAVE THE DATE

Autumn Beer, Data, + Drugs

Beer, Data, + Drugs is an invite-only event to celebrate working in drug discovery. Mark your calendars for Thursday, October 27th at Abzu Copenhagen.
LEARN MORE >

Abzu recognized as a Cool Vendor in artificial intelligence

Abzu is named a “Cool Vendor” in the 2022 Gartner® “AI Governance and Responsible AI — From Principles to Practice” report.

READ MORE >

READ THE REPORT >

Abzu is a Gartner Cool Vendor 2022

Abzu accelerates scientific research

Publications + preprints

The QLattice cited in Bioinformatics
The QLattice cited in American Journal of Obstetrics and Gynecology
The QLattice cited in BMC Medical Informatics and Decision Making
The QLattice cited in Applied Energy
SEE ALL PUBLICATIONS >

What makes Abzu unique?

Abzu was born from the desire to challenge the fundamental assumptions of contemporary, black-box AI. Watch Abzu’s story in 3 minutes.

Play Video about Lykke Pedersen, Head of RNA Therapeutics at Abzu, explains about Abzu
WHY ABZU >
ABOUT ABZU >
MEET THE ABZOIDS >

Abzu has been featured in

ABZU BUZZROOM >

Contact Abzu

It’s easy to get in touch with an Abzoid.

Contact form

Fill out the form below, and an Abzoid will be in touch in 24 hours.

Email us

Contact Sales at sales@abzu.ai or a scientist at science@abzu.ai.

Call us

Reach us during standard CET business hours at +45 31 23 47 64.